Covid-19 Antibody Cocktail
- All
- News
- Videos
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
As Delta Surges, Demand Explodes For Antibody Cocktails. This Is Why
Outside, in letters a foot tall, the wall of the trailer reads: "GET TESTED. GET TREATED. CRUSH COVID."
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Cocktail Antibodies Injection Used First Time In Andhra Pradesh
A hospitalin Andhra Pradesh's Guntur district has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
-
First Covid Patient Treated With 'Antibody Cocktail' In India Discharged
The first COVID-19 patient in India who was treated with a monoclonal antibodies cocktail was discharged from a hospital in Haryana today, a day after he was administered the jab.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Astrazeneca Starts Trial Of COVID-19 Antibody Treatment
British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
As Delta Surges, Demand Explodes For Antibody Cocktails. This Is Why
Outside, in letters a foot tall, the wall of the trailer reads: "GET TESTED. GET TREATED. CRUSH COVID."
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Cocktail Antibodies Injection Used First Time In Andhra Pradesh
A hospitalin Andhra Pradesh's Guntur district has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
-
First Covid Patient Treated With 'Antibody Cocktail' In India Discharged
The first COVID-19 patient in India who was treated with a monoclonal antibodies cocktail was discharged from a hospital in Haryana today, a day after he was administered the jab.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Astrazeneca Starts Trial Of COVID-19 Antibody Treatment
British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
